Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WAHEEDA NAZNEEN

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1124237532
CMS profile
1021782
Location
DETROIT, MI

General Payments · PY2018–2024

$3,454.75

  • Reported across 166 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$710.20

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $710.20 35

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $101.21 6
PY2019 $327.35 17
PY2020 $336.28 11
PY2021 $529.08 27
PY2022 $838.72 37
PY2023 $611.91 33
PY2024 $710.20 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $23.71 02/21/2024 Food and Beverage Undisputed 01/23/2026 1078893297 CMS
Actelion Pharmaceuticals US, Inc. $31.84 06/07/2024 Food and Beverage Undisputed 01/23/2026 1078893253 CMS
Actelion Pharmaceuticals US, Inc. $15.48 11/19/2024 Food and Beverage Undisputed 01/23/2026 1078893223 CMS
Amgen Inc. $21.52 07/11/2024 Food and Beverage Undisputed 01/23/2026 1115962793 CMS
AstraZeneca Pharmaceuticals LP $15.09 03/08/2024 Food and Beverage Undisputed 01/23/2026 1104689822 CMS
AstraZeneca Pharmaceuticals LP $17.19 08/06/2024 Food and Beverage Undisputed 01/23/2026 1104458192 CMS
AstraZeneca Pharmaceuticals LP $19.27 10/16/2024 Food and Beverage Undisputed 01/23/2026 1105372206 CMS
AstraZeneca Pharmaceuticals LP $15.37 12/03/2024 Food and Beverage Undisputed 01/23/2026 1105472595 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.42 05/02/2024 Food and Beverage Undisputed 01/23/2026 1086264457 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.41 05/22/2024 Food and Beverage Undisputed 01/23/2026 1086134316 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.91 08/08/2024 Food and Beverage Undisputed 01/23/2026 1086107460 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.59 10/17/2024 Food and Beverage Undisputed 01/23/2026 1086135719 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.72 02/06/2024 Food and Beverage Undisputed 01/23/2026 1117882100 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.14 06/04/2024 Food and Beverage Undisputed 01/23/2026 1117882098 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.55 09/24/2024 Food and Beverage Undisputed 01/23/2026 1117882104 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.02 12/17/2024 Food and Beverage Undisputed 01/23/2026 1117882102 CMS
GENZYME CORPORATION $28.22 01/09/2024 Food and Beverage Undisputed 01/23/2026 1139805990 CMS
GENZYME CORPORATION $17.74 02/20/2024 Food and Beverage Undisputed 01/23/2026 1139806008 CMS
GENZYME CORPORATION $22.99 11/05/2024 Food and Beverage Undisputed 01/23/2026 1139806090 CMS
GlaxoSmithKline, LLC. $14.20 01/31/2024 Food and Beverage Undisputed 01/23/2026 1116368604 CMS
GlaxoSmithKline, LLC. $16.56 07/08/2024 Food and Beverage Undisputed 01/23/2026 1115754344 CMS
GlaxoSmithKline, LLC. $15.88 08/12/2024 Food and Beverage Undisputed 01/23/2026 1116547839 CMS
GlaxoSmithKline, LLC. $13.81 09/12/2024 Food and Beverage Undisputed 01/23/2026 1116701821 CMS
GlaxoSmithKline, LLC. $14.48 09/25/2024 Food and Beverage Undisputed 01/23/2026 1116349802 CMS
Grifols USA, LLC $23.98 04/16/2024 Food and Beverage Undisputed 01/23/2026 1124750915 CMS
Grifols USA, LLC $20.35 10/01/2024 Food and Beverage Undisputed 01/23/2026 1124750913 CMS
JAZZ PHARMACEUTICALS INC. $20.43 04/30/2024 Food and Beverage Undisputed 01/23/2026 1150200271 CMS
JAZZ PHARMACEUTICALS INC. $29.01 05/27/2024 Food and Beverage Undisputed 01/23/2026 1150200273 CMS
Merck Sharp & Dohme LLC $19.97 07/09/2024 Food and Beverage Undisputed 01/23/2026 1141856316 CMS
Mylan Specialty L.P. $23.55 01/05/2024 Food and Beverage Undisputed 01/23/2026 1147308805 CMS
Mylan Specialty L.P. $24.91 02/12/2024 Food and Beverage Undisputed 01/23/2026 1147320788 CMS
Pulmonx Corporation $24.38 11/27/2024 Food and Beverage Undisputed 01/23/2026 1087849822 CMS
Resmed Corp $20.56 12/11/2024 Food and Beverage Undisputed 01/23/2026 1140204109 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.00 03/05/2024 Food and Beverage Undisputed 01/23/2026 1137642148 CMS
United Therapeutics Corporation $15.95 03/07/2024 Food and Beverage Undisputed 01/23/2026 1149464918 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.